GSE130401 trametinib YAP 4 v 3 human dn (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE130401_trametinib_YAP_4_v_3_human_dn.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE130401_trametinib_YAP_4_v_3_human_dn.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE130401_trametinib_YAP_4_v_3_human_dn.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE130401_trametinib_YAP_4_v_3_human_dn.

Results found

Linked to

 

Label

Description

 

Gene

H19 imprinted maternally expressed transcript

Gene

small nucleolar RNA host gene 29

Gene

H3.7 histone (putative)

Gene

long intergenic non-protein coding RNA 2593

Gene

ATPase H+ transporting V1 subunit G2

Gene

PSMG3 antisense RNA 1

Gene

firre intergenic repeating RNA element

Gene

myocardial infarction associated transcript

Gene

glucosylceramidase beta 1 like, pseudogene

Gene

MIR210 host gene

  • Gene

    H19 imprinted maternally expressed transcript


  • Gene

    small nucleolar RNA host gene 29


  • Gene

    H3.7 histone (putative)


  • Gene

    long intergenic non-protein coding RNA 2593


  • Gene

    ATPase H+ transporting V1 subunit G2


  • Gene

    PSMG3 antisense RNA 1


  • Gene

    firre intergenic repeating RNA element


  • Gene

    myocardial infarction associated transcript


  • Gene

    glucosylceramidase beta 1 like, pseudogene


  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.